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DevelopmentTranscriptional regulation plays key roles in many biological processes. The regulation is dynamic in time and
space. Identifying transcription factors that play major roles in a developmental time course is very
important for understanding the regulation. This cannot be realized by studying the relation between the
expression of individual genes. We developed a gene-set analysis approach to study master regulators and
their actively regulated targets during a time course from gene expression data. We applied the method to a
mouse liver development data and a mouse embryonic stem cell (mESC) development data, and identiﬁed 14
and 9 transcription factors that play major regulatory roles in the two development courses, respectively.
Some transcription factors could not be identiﬁed as active in the process by studying their correlation with
individual targets. The method was also extended for studying other regulation factors or pathways from
time-course expression data.© 2009 Elsevier Inc. All rights reserved.Introduction
Biological processes rely on ﬁnely orchestrated regulation of gene
expression. Different levels of regulation, including transcriptional
regulation by transcription factors (TFs), post-transcriptional regula-
tion by microRNAs (miRNAs) [1], etc, ensures biological processes on
their rails.
Transcriptional regulation is a dynamic process. Sequence infor-
mation has been used to discover targets of particular regulatory
elements (TFs, miRNAs, etc) computationally [2]. ChIP-chip, RNAi and
other similar experiments have also been employed for the discovery
of TF targets [3–6]. These computational and experimental techno-
logies have helped gain insights into the function of the regulatory
elements at a certain spatial and temporal point. However, transcrip-
tional regulation may be tissue speciﬁc and change from time to time
according to the inner and outer environment of the cell [7,8], and
these technologies provide a static view, or a snapshot of the complex
scene under study.
Transcriptional regulation plays a key role in development
processes and cell destiny determination, and gene expression proﬁles
have been employed to study the regulation during developmental
time course. For example, liver is a versatile organ and executes awide
variety of fundamental functions for life, and dynamic transcriptional
regulation is essential to the development of such a complex organ. In
a previous work, we discovered several TFs which function at different
stages of the mouse liver development process respectively [8]. The).
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ll rights reserved.differentiation and development of embryonic stem cells (ESCs) is a
biological process of great interest. ESCs have the pluripotency
property, which makes them able to differentiate into a wide range
of cell types [9,10]. Both the maintenance of their undifferentiated
state and triggering of their differentiation depend on precisely tuned
gene expression which constantly varies over time [3,5,6,11]. There
have been studies focusing on deciphering the regulatory networks
for some functional TFs during mESC differentiation [12–14].
There have been several methods proposed to study dynamics of
gene regulation in biological processes using expression time series.
For example, Pearson Correlation Coefﬁcient (PCC) [15], the local
clustering (LC) coefﬁcient [16], mutual information (MI) [17] and
trend correlation (TC) scores [18] have been proposed to evaluate the
correlation between time series of two genes. Assuming that
associated genes have similar expression patterns, these methods
could reveal possible functional or expressional associations and be
used to construct biological networks [17], but TFs that play major
roles in a time course are hard to be revealed from such results. It has
also been shown that for many cases, the correlation between the
expression time series of a single TF and its targets can be weak
[18,19], and the absolute values of such measurements are often
incomparable among different TFs, making it difﬁcult to set thresholds
for detecting active TFs from the correlation of individual gene pairs.
When studying development courses it is important to identify
master TFs that play dominant roles in regulating the expression of
their target genes. Considering the aggregation of targets of a regulator
may help solve the aforementioned problems because the larger
proportion of a regulator's targets show similar expression patterns to
it, themore likely it is amaster TF. Enlightened bygene-set enrichment
analysis or GSEA for static expression data [20], we adopted a gene-set
analysis strategy to discover master regulators and their actively
Fig.1. The pipeline of the strategy. The strategy is executed in a two-stepmanner. In the ﬁrst step, we use correlation scores between time series of a TF and genes tomeasure and rank
the correlation between their expression proﬁles (red arrow). In the second step, the normalized enrichment score (NES) is obtained for a particular gene set. Gene-set resampling
(green arrow) is used to evaluate the signiﬁcance of enrichment (blue arrow) and normalize the original enrichment scores (yellow arrow). If there are more than one candidate
target set, all the permuted NESs are used for the calculation of a q-value, which degenerates to p-value if there is only one candidate set (black arrows).
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no prior knowledge of the function or expression of regulators, allows
both positive and negative correlation and potential time lag in the
TF-target regulation, and enables the discoveryof functional TFswhose
expressions are weakly correlated with targets even in a short time
course. Applying the strategy on a mouse liver development dataset
[8], we identiﬁed 14 master TFs in the liver development course. Most
of these TFs have been reported to participate in the liver development
process except two (IRF8 and IRF4). They have not been reported as
related to liver development, but this study shows that these two TFs
also play key roles in liver development. We also explored a dataset of
mouse ESC (mESC) differentiation process [21] with the method and
highlighted ninemaster TFs, eight of which have been reported to play
important roles in stem cell differentiation except GC, which is shown
functional in this process by this study. Some of the identiﬁed master
TFs cannot be discovered as active if their effects on targets were not
studied in the gene-set analysis manner. The method was also
extended to analyze other types of regulators and active pathways
from time-course expression data, and was developed as a software
TAGS (Time-series Analysis for Gene Set) for the convenience of
biologist users. The software is available at http://bioinfo.au.tsinghua.
edu.cn/member/yliu/TAGS.
Results and discussion
Identifying master TFs and their actively regulated targets in a
time course
We use a two-step strategy to discover master TFs and their targets
actively regulated by them during a speciﬁc time course from a set of
candidate regulators and the sets of their validated or predicted target
genes. In the ﬁrst step, for each TF, we use absolute cross-correlation
function (CCF) tomeasure the correlation between its expression time
series and those of all the genes on a microarray. We choose absolute
CCF to take into account both positive and negative correlation and
potential time lag between the expression proﬁles of a TF and its
target. The genes are ranked according to the maximums of their
absolute CCFs deﬁned as correlation scores (see Materials and
methods for the deﬁnition). The relative strength of the correlation
is used for ranking the genes rather than these values per se. This is
suitable even if the correlation measurements (CCFs) are not very
large. In the second step, we study the target set of each TF with a
running-sum statistic as in the GSEA method [20]. Based on the
assumption that master TFs dominate in regulating their targets'
expression, we study the TF's target set to see whether a signiﬁcant
proportion of its targets behave more similarly to the TF than other
genes. An enrichment score is calculated to reﬂect the enrichment of aTable 1
Master TFs obtained on the mouse live development data and validated target sets.
TF Function descriptiona
HNF4a Lipid metabolic process, liver development [22]
NFE2L2 Regulation of embryonic development
SFPI1 Granulocyte differentiation, lymphocyte differentiation, macrophage differentia
CEBPA Liver development, regulation of cell proliferation, macrophage differentiation,
POU5F1 (Endodermal and mesodermal) cell fate commitment
PPARA Fatty acid, glucose and lipid metabolic processes, regulation of fatty acid metab
IRF8 Myeloid cell differentiation
GATA1 The dominant action of GATA1s leads to hyperproliferation of a unique, previou
progenitor [37], critical hematopoietic transcription factor [38]
ZBTB7B Cell differentiation, multicellular organismal development
KLF3 Adipogenesis with CtBP [39], highly expressed in erythroid cells [40]
SOX17 Angiogenesis, vasculogenesis
NR5A2 Bile acid metabolic process, cholesterol homeostasis, primitive streak morphog
IRF4 Myeloid dendritic cell differentiation
SP1 Deﬁnitive hemopoiesis, liver development
a Function annotations are retrieved from GO (http://www.geneontology.org) and the reTF's targets toward the top of the corresponding gene ranking
generated in the ﬁrst step. This circumvents the potential need to
determine a threshold of the correlation with regard to whether a
target gene is regulated by the TF, and enables the discovery of TFs
whose correlation with targets are weak but signiﬁcant. A permuta-
tion strategy is used for signiﬁcance evaluation. The strategy can
produce two types of discoveries: master TFs and their actively
regulated targets during a time course. Those actively regulated
targets constitute the so-called ‘leading-edge subset’ of the target
genes. Fig. 1 shows the pipeline of the method. More details are
described in the Materials and methods section. As examples, we
applied the strategy to a mouse liver development dataset and amESC
differentiation dataset to study transcriptional regulation during these
two processes.
Master TFs and their regulated targets in mouse liver development
We applied the strategy on a mouse liver development dataset [8].
The data contain 14 time points across the developmental course,
which consist of E11.5 (embryonic day 11.5), E12.5, E13.5, E14.5, E15.5,
E16.5, E17.5, E18.5, Day0 (the day of birth), Day3, Day7, Day14, Day21,
and normal adult. 303 TFs and their experimentally validated target
sets got from TRANSFAC were analyzed with the strategy, and 100
runs of permutation were done for signiﬁcance evaluation. We
identiﬁed 14 signiﬁcant TFs with FDRs less than 10.0%. Table 1 gives
these TFs and the description of their known functions associatedwith
liver development.
It can be seen from Table 1 that most of these 14 TFs can be divided
into three functional groups: (1) TFs involved in the developmental
process; (2) TFs with hematopoietic function which is an important
function of fetal liver; (3) TFs participating in liver metabolic
processes such as fatty acid, glucose and lipid metabolic processes.
Some of these TFs are well-known liver-speciﬁc TFs, such as HNF4a
and CEBPA, and have been reported to be critical to liver development.
HNF4a plays critical roles in liver development, including control-
ling hepatic epithelial structure and liver sinusoidal organization [22].
It binds to almost half of the transcribed genes tested in the adult
mouse liver studied in a recent ChIP-array study [4]. Although HNF4a's
validated target set only contains 14 genes according to the current
version of TRANSFAC, it is enough for the strategy to identify this
important TF with FDR 0.000. Fig. 2a shows the expression proﬁles for
HNF4a and its targets. The targets in the leading-edge subset are
indicated in Fig. 2, and these genes show expression patterns more
similar to HNF4a than the other genes, so they are more likely to be
actively tuned by HNF4a and are participators in the development
process. HNF4a can both activate and repress the expression of its
targets according to our data (Fig. 2a). Table 2 gives the functionNormalized enrichment score q-value
3.460 0.000
3.501 0.000
tion 2.715 0.044
negative regulation of cell proliferation 2.673 0.049
2.720 0.050
olic process, epidermis development 2.731 0.060
2.753 0.068
sly unrecognized yolk sac and fetal liver 2.579 0.070
2.523 0.070
2.780 0.073
2.529 0.075
enesis 2.443 0.090
2.425 0.092
2.321 0.098
ferenced literatures.
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information with Fig. 2a could help ﬁlter out some irrelevant genes
which do not reside in the leading-edge subset and probably do not
function in the liver development process.
SP1 is another TF important to liver development discovered with
FDR 0.098. SP1 has been reported to be essential to embryonic
development, and SP1 knockout mice die around E10.5. A very recent
study shows that SP1/SP3 compound heterozygous mice are not
viable, and suffer from a spectrum of developmental abnormalities of
different organs [23]. This implies that unlike HNF4a, which is speciﬁc
to liver, SP1 may play a more extensive role in the development
procedure, and the development of different organs may share some
common molecular mechanisms. SP1 is also involved in deﬁnitive
hemopoiesis (according to GO), which is a function of the fetal liver.
Fig. 2b shows the time series of SP1 and its targets. It has been
reported that liver becomes a major site of fetal hemopoiesis around
E10.5 to E12.5, and this is consistent with SP1's highest expression
value at E12.5 according to our data (Fig. 2b). Like HNF4a, SP1 is able
to both enhance and repress its targets' expression, while the more
targets compared to those of HNF4a may indicate the more
comprehensive function of SP1.
Besides TFs relevant to development, there are also signiﬁcant TFs
which take part in some metabolic processes that take place in the
liver. These TFs include PPARA, KLF3 and NR5A2 (Table 1). HNF4a also
takes part in the lipid metabolic process according to its GO
annotation. This is consistent with its up-regulation during the time
course (Fig. 2a), because in the late phase of embryonic development
the liver begins to function as a metabolic organ.
There are two other TFs, IRF8 and IRF4, which play a part in
myeloid cell differentiation according to existing literature (Table 1)
and seem not directly relevant to liver development. Besides the
common hematopoietic function of liver and myeloid, further
literature mining shows that normal mouse liver can form myeloid
cell clusters which contain dendritic cell progenitors in vitro [24].
Since there may be commonmechanisms for a variety of development
processes according to the above analysis, and IRF8 and IRF4 both have
smaller FDRs than SP1, the crucial TF for liver development (Table 1),
we infer that these two TFs may play key roles in mouse liver
development, which deserves further study.
We compared the signiﬁcant TFs discovered here with the TFs
which were considered over-represented at different stages of liver
development in our previous study [8]. There are two common TFs,
HNF4a and SP1. These twoTFs were considered to be over-represented
inmore than one stage in [8] (HNF4a in Stage I and IV, and SP1 in Stage
II and IV). This indicates that the TFs discovered in this study play
dominant roles constantly during the whole liver development
process. The TFs only functioning in a particular stage in [8] are not
of interest in the current work, because liver development is
considered as a whole process here. The TFs in Table 1 are critical to
liver development for they always dominate in regulating theirFig. 2. Expression for HNF4a and SP1 and their validated targets in the liver development
correlation scores are indicated by color on the left side of the heatmaps. (a) HNF4a and itstargets' expression during this process for its normal running. Note
that the above results do not mean that other TFs (such as the ones
discovered in [8]) do not contribute to liver development. The 14
signiﬁcant TFs are ‘master’ TFs. This means that their regulatory effect
can be reﬂected by a comparatively large part of its TFs' expression,
which implies they may have master functions during the develop-
ment process.
We then studied TFs with their predicted targets under the same
framework, and investigated TFs with motifs from TRANSFAC and
their predicted targets with p-values lower than 10−5 by the Staden's
method [2]. We obtained eight signiﬁcant TFs with FDRs less than
10.0%. Table S1 gives these TFs and the description of their known
functions associated with liver development. The two most relevant
TFs, HNF4a and SP1, are both in the list of master TFs resulting from
the predicted targets as expectation. Fig. S1 shows the time series of
HNF4a and its predicted targets. Independent liver-speciﬁc ChIP-array
data has reported that HNF4a bounds to 1575 genes in the liver [4],
and we used it as a validation of the predicted targets in the leading-
edge subset. 103 targets in the leading-edge subset are validated by
the experiment in [4]. We then applied the chi-square test to check
whether the leading-edge subset is enriched with targets validated by
experiments. The obtained chi-square statistic is 90.0122 with p-value
of almost 0. We can see apparently from the expression proﬁles that
expression patterns of genes in the leading-edge subset either
positively or negatively correlate with that of HNF4a (Fig. S1 (A)).
We infer these genes are regulated by HNF4a, either enhanced or
repressed, during mouse liver development. Note that this does not
mean that other genes are deﬁnitely not targets of HNF4a, but only
that those genes are not actively regulated by it during the speciﬁc
development process (Fig. S1 (B)). The consistency between our
results and the experiments together with the gene function
annotations in Table 2 and expression proﬁles in Fig. S1 (A) conﬁrms
that the targets in the predicted leading-edge subset are actively
regulated by HNF4a and play important roles during liver
development.
Master TFs and their regulated targets in mESC differentiation
We then used a mESC differentiation dataset generated by
Hailesellasse Sene et al. [21]. The data contain gene expression time
series for three biologically equivalent but genetically distinct mESC
lines (R1, J1, and V6.5) at 11 time points (0 h which represents
undifferentiated mESCs, 6 h, 12 h, 18 h, 24 h, 36 h, 48 h, 4 d, 7 d, 9 d,
and 14 d). We explored the potential regulation relationships between
62 TFs and their predicted targets ranked top 100 by the Staden's
method [2] under 100 runs of permutation. We identiﬁed 15, 3 and 23
signiﬁcant TFs with FDRs less than 15.0% for R1, J1 and V6.5 cell lines,
respectively (We also analyzed similarly TFs and their validated target
sets, and Table S2 gives the results). Table 3 shows nine TFs considered
signiﬁcant according to the results of at least two of the cell lines withdata. The targets with blue names are in the corresponding leading-edge subsets. The
targets. (b) SP1 and its targets.
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Table 2
Function annotations for the validated targets of HNF4a got from TRANSFAC.
Transcripts Ofﬁcial
symbol
Function descriptiona In the leading-edge
subset of HNF4ab
NM_011044 Pck1 Gluconeogenesis, lipid metabolic process, glycerol biosynthetic process from pyruvate Y
NM_001039185 Ceacam1 The sole receptor for mouse hepatitis virus A59 in both liver and brain, and its deletion from the mouse
renders the mouse completely resistant to infection by this virus [41]; regulates insulin clearance in liver [42]
Y
NM_001039186
NM_001039187
NM_011926
NM_011367 Shbg Monosaccharide-induced lipogenesis reduced hepatic HNF4a levels, which in turn attenuated Shbg expression [43] Y
NM_023114 Apoc3 Cholesterol metabolic process, triacylglycerol catabolic process, triacylglycerol metabolic process,
triacylglycerol mobilization
Y
NM_024264 Cyp27a1 Oxidation reduction, both its genotype and gender affected the regulation of hepatic bile acid, cholesterol,
and fatty acid metabolism [44]
Y
NM_007543 Ceacam2 Component of cell surface N
NM_007820 Cyp3a16 Oxidation reduction N
NM_007428 Agt Positive regulation of fatty acid biosynthetic process, kidney development and function [45] N
NM_019546 Prodh2 Glutamate biosynthetic process, oxidation reduction, proline catabolic process, proline metabolic process N
NM_009693 Apob Cholesterol homeostasis, lipid metabolic process, lipoprotein metabolic process, triacylglycerol catabolic process,
triacylglycerol mobilization, in utero embryonic development
N
NM_011038 Pax4 Organ morphogenesis, positive regulation of cell differentiation N
a Function annotations are retrieved from GO and the referenced literatures.
b Whether this gene is in the leading-edge subset of the validated targets.
6 Y. Liu et al. / Genomics 94 (2009) 1–10the description of their functions. Table S3 shows detailed information
and time series shown by heatmaps of the signiﬁcant TFs and their
targets in the leading-edge subsets according to each of the three cell
lines respectively.
The TFs in Table 3 are considered to be master TFs for the general
mESC differentiation process since they are signiﬁcant in at least two
of the three cell lines, while cell-line-speciﬁc signiﬁcant TFs may
reﬂect inherent genetic discrepancies and unique regulation in each
cell line (Table S3). Most of the master TFs in Table 3 are critical to the
balance of self-renewal and differentiation into different cell types,
which are the two most important characteristics of ESCs [9,10].
NANOG is reported to be signiﬁcant by both R1 and V6.5 mESC
lines. It is a leading TF for ESC to maintain self-renewal and pluri-
potency according to its GO annotations and literature. Fig. 3 shows
the time series of NANOG and its predicted targets in R1 mESC line. It
can be seen that NANOG can both activate and suppress its targets'
transcription, which is consistent to the independent study of Loh
et al. [6]. Most of its predicted targets are in the intersection of the
leading-edge subsets obtained from R1 and V6.5 lines and show
similar expression patterns to NANOG, and this may be an indication
of NANOG's major role in mESC. These targets are more likely to be
true targets and actively regulated by NANOG following the similar
reasoning for liver development. Independent ChIP-chip [3], ChIP-PET
[6] and RNAi [5] data for NANOG are available and we used them to
validate our predication. There are 13 targets that are in the leading-
edge subset and are reported to be bound by NANOG with high
conﬁdence in those data. All genes outside the leading-edge are not
direct targets of NANOG according to those experiments. Chi-squareTable 3
Master TFs obtained on the mESC data and predicted target sets.
TF Function descriptiona
HOXA7 Multicellular organismal development, embryonic skeletal morphogenesis
EVI1 In utero embryonic development, post-embryonic development, multicellula
development, forebrain development, embryonic forelimb morphogenesis
ESR1 Cell growth, negative regulation of mitosis
EN1 Multicellular organismal development, neuron differentiation, embryonic fo
E4F1 Embryonic development
NANOG Embryonic development, stem cell differentiation and maintenance, multice
TBX5 Embryonic forelimb morphogenesis, multicellular organismal development,
MEIS1 Multicellular organismal development, deﬁnitive hemopoiesis
GC Vitamin D metabolic process
a Function annotations are retrieved from GO.
b Results got from the cell line whose result reports the corresponding TF with the lowestest was used to check whether the leading-edge subset is enriched
with targets validated by experiments. The obtained chi-square
statistic is 6.8555 with p-value 0.008837. We infer the other targets
not yet validated in the leading-edge subset are also controlled by
NANOG during mESC differentiation.
One of the nine TFs in Table 3, GC, takes part in vitamin D (VD)
metabolism, which seems not directly relevant to ESC differentiation,
whereas it is considered signiﬁcant by R1 and V6.5 mESC lines.
Interestingly, a recent study showed that exposure to VD3 can enhance
the differentiation of mESCs into osteoblasts, and osteoinduction is an
intricate dynamic process [25]. This indicates that GC may also take
part in this process, which deserves further study.
Investigating the correlation between expression time series of a
TF and each of its targets individually and comparing it with the
results from gene-set approaches in this paper could be helpful to
highlight the power of the latter. The correlation score between each
target and NANOG is indicated in Fig. 3, and it shows that only a small
portion of the targets have their expression strongly correlated with
that of NANOG. In fact, the correlation scores for 38 out of the 69
targets are below 0.4, with the lowest only 0.136 despite of NANOG's
deﬁnitely important roles during ESC differentiation. If we make
inferences based only on such individual correlation, it is unlikely to
discover TFs such as NANOG. However, this critical TF is detected
signiﬁcant when we apply gene-set analysis. Considering that the
values of correlation measurements can be small between the
expression time series of a single TF and its targets [18,19], gene-
set-based strategies such as the one in this paper can help to reveal
some of the important TFs and their regulated targets.Normalized enrichment scoreb q-valueb
4.399 0.000
r organismal 4.101 0.000
4.083 0.000
relimb morphogenesis 3.908 0.000
3.587 0.002
llular organismal development 3.428 0.007
morphogenesis of an epithelium 2.843 0.025
3.119 0.050
2.055 0.144
t FDR.
Fig. 3. Expression for NANOG and its predicted targets in R1 mESC line. The targets with red and blue names are in the intersection of the leading-edge subsets by R1 and V6.5 mESC
lines, the results fromwhich report NANOG signiﬁcant, where targets with red names are also validated by independent experiments and actively regulated by NANOG during mESC
differentiation. The correlation scores are indicated by color on the left side of the heatmap.
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Besides TFs, other regulators can be interrogated in the similar way
presented above, for example, miRNAs, which are approximately 22 nt
RNAs that exert their function after transcription by targetingmRNAs for
cleavage or translational repression [1]. But it ismore difﬁcult to detect a
relatively strong correlation between the expression of miRNA and its
target, especially for the repressionmechanism. This makes the ranking
criterion based on correlation less reasonable for the analysis ofmiRNAs.
Besides, the expression time series of regulators under study such as
miRNAsmay beunavailable due to experimental limitation. Considering
the above situations, we generalized the strategy for analyzing
regulation using only targets' expression time series.
The difference between the current extension for miRNA analysis
and the basic procedure lies in the ranking criteria. Speciﬁcally, we
rank the genes according to their differential expression rather than
expression correlation with the regulator so that genes that are
differentially expressed (up- or down-regulated) over time will be
ranked at the top of the list, and there is only one ranking for all gene
sets if multiple sets are analyzed. The underlying rationale is that if
expression of most targets of a regulator varies signiﬁcantly across
time during a time course, this regulator is likely to be an active playerin the corresponding biological process. Different criteria can be used
for the ranking task. A simplest one is the variance of each gene's
expression across the time course. Some existing methods, such as
EDGE [26], maSigPro [27] and MESA [28] could also provide gene
ranks according to the genes' differential expression.
We analyzed miRNAs and their target sets with the mouse liver
development dataset. Table S4 gives signiﬁcant miRNAs and their
functions. Interestingly, there is one signiﬁcant miRNA, miR-451,
which is regulated by GATA1, and GATA1 is also amaster TF discovered
by our transcriptional regulation analysis (Table 1). This gives a clue
that different levels of regulation mechanisms may cross-talk with
each other to form a comprehensive regulatory network in one
process, and analysis of the dynamics of different regulatory mecha-
nisms with the framework in this paper could endow a promise for
unveiling at least part of this whole picture.
We developed a software package called Time-series Analysis for
Gene Set or TAGS implementing the whole framework for gene-set
analysis of expression time series, and used it to analyze a variety of
expression time series for different purposes. For example, pathway
analysis incorporates either pathway or functional annotations in
search for consistent changes in gene expression. Methods for
pathway analysis include GSEA [20], SAFE or Signiﬁcance Analysis of
8 Y. Liu et al. / Genomics 94 (2009) 1–10Function and Expression [29], SAM-GS, an extension of the SAM
(Signiﬁcance Analysis of Microarray) method to gene-set analyses
[30], GSA [31], Sub-GSE [32], etc. These methods have been applied to
analyze a wide range of biological data, including data from static
microarray experiments [20], eQTL [33] and data for genomewide
association study [34]. However, no applications to time-course
microarray experiments have yet been published to the authors'
best knowledge. We used TAGS to study pathways functioning in
human brain ageing by the same strategy for the miRNA analysis, and
obtained several signiﬁcant pathways. We also analyzed the cytoge-
netic sets (C1) downloaded from the Molecular Signature Database
(MSigDB) [20] to study structurally associated genes with TAGS. The
software is available for free academic use at http://bioinfo.au.
tsinghua.edu.cn/member/yliu/TAGS.
Other correlation-based methods have been developed for the
construction of biological networks based on the pairwise correlation
between genes. Examples include local clustering (LC) [16], relevance
networks [17] and trend correlation (TC) [18]. The observed correla-
tion relationships with such methods are effects of all possible
functional or expressional associations and they are not designed to
reveal the TFs that play a major role in a time course. The TAGS
strategy discovers master regulators during a particular time course
by investigating the enrichment of their actively regulated targets
towards the top of ranks of the correlation score. We expect that the
current work will constitute an advance in exploring the dynamic
characteristics of biological processes.
Materials and methods
Ranking genes with expression time series
Measuring the correlation between a TF and a gene
The basic assumption concerning the dynamic regulation is that if
a TF plays an important role during a time course, its targets should
exhibit similar expression patterns, although there will be some time
lag because it may take some time for the TF to function.We use cross-
correlation function (CCF) for the evaluation of the correlation
between a TF and a gene with consideration of the possible time lag.
Speciﬁcally, let Xi(t) and Xj(t) be time series of a TF and a gene,
respectively, t=1, …, n. The CCF between the two time series is
CCF τð Þ =
P
s Xi s + τð Þ− Xi
 
Xj sð Þ− Xj
h in o
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃP
s Xi sð Þ−Xi
 2q ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃP
s Xj sð Þ−Xj
h i2r :
Then the correlation score for the considered gene is deﬁned as
C = maxτ V 0 abs CCF τð Þð Þ:
The range of correlation scores is [0,1].The absolute value takes
both positive and negative correlation into account, and only non-
positive τs are considered since only TFs rather than targets can have
phase lead. For a particular TF, genes are ranked according to their
correlation scores.
Finding differentially expressed genes across the time course
Several methods for ranking the genes according to their
differential expression in the dataset can be used for the miRNA
analysis in this study. Adopting the terms used in classiﬁcation
studies, genes whose expressions change signiﬁcantly across the time
course can be called differentially expressed genes or DE genes.
As a simple and straightforward method, the variance of each
gene's expression across the time series can be calculated as a
measure of the gene's differential expression. We can rank the genes
according to their variances. The variance can reﬂect the overall
ﬂuctuation of the expression values across the time course. Thisstrategy is suitable for scenarios in which one does not care about the
order of the expression values, e.g., when studying the gene
expression proﬁles in a series of experimental situations. In some
cases, even if the investigation is some time-relevant, variance is a
suitable measure when only very few time points were observed.
Gene ranks generated from existing methods can also be used.
Examples of such methods include EDGE [26] for signiﬁcance analysis
of time-coursemicroarray experiments, maSigPro [27] that can handle
multi-group time series data, and MESA [28] for cell-cycle types of
time series data. Actually, any method can be used to provide gene
ranking as long as it can produce an ordered list of genes that are
meaningful for the underlying study. TAGS integrates some of the
above ranking criteria.
Evaluating the enrichment of a target set
An enrichment score ES for each target set (corresponding to a
regulator) is calculated with a running-sum statistic, following the
strategy similar to the GSEAmethod [20]. Let S be the studied target set
of NH targets of a TF, and let G={gj; j=1, 2,…, N} be the ordered list of
genes corresponding to the TF, where j is the gene order index and N is
the number of genes in the list.We can calculate two sums Phit (S, i) and
Pmiss (S, i) as
Phit S; ið Þ =
X
gjaS
j V i
1
NH
;
Pmiss S; ið Þ =
X
gjgS
j V i
1
N − NH
:
A counter is calculated and its value at position i is
counter S; ið Þ = Phit S; ið Þ− Pmiss S; ið Þ;
and the enrichment score of target set S is
ES Sð Þ = max
i
counter S; ið Þf g:
The range of ES values is [0,1]. We denote the position where the
maximum is reached as i0. The genes in set S ranked above or at
position i0 are called the leading-edge subset of the target set. Note
that there is no hard boundary between targets in the leading-edge
subset and those not. In this paper, we just take advantage of leading-
edge subset to retrieve targets under the control of their regulator in a
particular time course for further study.
We adopt a permutation strategy to assess the signiﬁcance of the
enrichment score. Speciﬁcally, a number of randomly selected gene
sets with the same size are generated, which is deﬁned as gene-set
permutation, and the enrichment scores of these gene sets on the
corresponding rank are calculated. The null distribution of the
enrichment score and the permutation p-value are estimated
according to these scores.
It is also possible to do other types of permutation. For example, by
randomly shufﬂing the time points of the time series, any patterns in
the gene expression across the time course will be randomized. But
this kind of time-point permutation does not take effect for the
calculation of CCF in our basic scenario. However, the extension for the
miRNA analysis could apply this permutation strategy so it is also
implemented in TAGS.
Multiple comparisons
It has been reported that there might be bias toward assigning
higher enrichment scores to gene sets of large size [35]. We adjust for
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normalizing the enrichment scores with the mean of permuted scores
[20]. Let the enrichment score for a target set S generated from a
permutation p0 be ES(S, p0). The original and permuted normalized
enrichment score NES(S) and NES(S, p0) are given by
NES Sð Þ = ES Sð Þ
ES S;pð Þ ;
NES S;p0ð Þ =
ES S;p0ð Þ
ES S;pð Þ ;
where ES S;pð Þ is the mean of all the permuted enrichment scores for
target set S.
As in other genome-scale investigations, Bonferroni correction
can be applied to control the family-wise error rate when
performing multiple testing, which is stringent but may result in
too few or no discoveries when the number of candidate target sets
(regulators) m is large. Another widely accepted correction is to
control the False Discovery Rate or FDR [36]. We adopt the FDR
correction in our experiments. More speciﬁcally, the FDR for a set S0
is calculated as
FDR S0ð Þ =
eS;p NES S;pð Þz NES S0ð Þf g = m × tð Þ
eS NES Sð Þz NES S0ð Þf g =m
:
where t is the permutation time for each target set.
Adjustment and variations of the strategy
Weighted enrichment scores can be calculated to emphasize genes
of more importance. This can be useful when values of a particular
ranking criterion vary abruptly along the gene lists.We also provide an
option in the strategy to deﬁne tie genes when the difference between
two criterion values is small. Both the above options are implemented
in TAGS. See Supplementarymaterial for the formulation and technical
details of these options.
Mouse liver development data
We ﬁrst applied the strategy to a time series expression dataset of
mouse liver development [8]. It contains the expression proﬁles of
21561 mouse Refseq transcripts at 14 time points during the liver
development process, which include E11.5 (embryonic day 11.5),
E12.5, E13.5, E14.5, E15.5, E16.5, E17.5, E18.5, Day0 (the day of birth),
Day3, Day7, Day14, Day21, and normal adult. The expression is
measured with Mouse 430 microarrays (Affymetrix).
We used BioMart (http://www.biomart.org/biomart/martview/)
and MGI (http://www.informatics.jax.org/) to convert the TF identi-
ﬁers in TRANSFAC into RefSeq IDs, and then searched the expression
matrix for the expression time series of the TFs and got 303 time series
of TF transcripts and 63 time series corresponding to motifs. We then
selected from the expression matrix transcripts with their expression
values higher than 1.5-fold or lower than 1/1.5-fold compared to the
mean at any time point (8640 in total) for the correlation analysis.
mESC differentiation data
We then used a mESC differentiation dataset generated by
Hailesellasse Sene et al. [21]. The dataset has time series of 22690
genes in three biologically equivalent but genetically distinct mESC
lines (R1, J1, and V6.5), each line with 11 time points (0 h which
represents undifferentiated mESCs, 6 h, 12 h, 18 h, 24 h, 36 h, 48 h, 4 d,
7 d, 9 d, and 14 d) and 3 replicates at each time point. Two GeneChips
(MOE430A and MOE430B, Affymetrix) are used for each cell line.
MOE430B measures genes that are not very well characterized than
those onMOE430A according to the data analysis byHailesellasse Seneet al. [21], sowe used data generated byMOE430A for our analysis. The
data generated from R1, J1 and V6.5 cell lines were downloaded from
the GEO database (http://www.ncbi.nlm.nih.gov/geo/) with acces-
sion numbers GDS2666, GDS2668 and GDS2671, respectively. The 3
replicates were averaged to form one time series for each cell line.
The expressionmatrix contains 62 time series corresponding to the
motifs in TRANSFAC.We used the proposed strategy to analyze the TFs
for each of the three cell lines.
Target sets for the regulatory analysis
For each TF, we used its validated or predicted target genes as
the corresponding gene set. TFs and their true targets were
retrieved from the mouse/rat/human-subset of TRANSFAC FACTOR
TABLE (Release 2008.2). Rat/human targets in the table were
converted to their mouse homologues using BioMart (http://www.
biomart.org/biomart/martview/). 344 gene sets corresponding to
344 TF transcripts were constructed, each of which contains
validated targets of a TF. Note that typically these targets are
conﬁrmed to be bound by their TFs at a speciﬁc space and time
point, so whether they (and which subset of them) are regulated in
a particular time course needs to be studied.
Wegot thepromoterDNAsequences fromtheUCSCdatabase (http://
genome.ucsc.edu/). Each promoter sequence was taken 1000 bp
upstream to 200 bp downstream from the transcription start site (TSS).
All the motifs are represented by the Position Weight Matrices (PWMs).
Knownmotifswere got from the vertebrate subset of TRANSFAC (Version
9.3). The targetswerepredicted by the Staden'smethod [2]. Given amotif
M, base composition f and a match score S, the Staden's method can
calculate the p-value of the match score S, that is, the probability that a
randomly selected site has a score at least as high as S, and genes are
ranked according to their p-values. The base composition f is calculated
from the promoter sequences. Thematch score S is obtained by scanning
the promoter sequence of each genewith the PWMofM.We constructed
twoeditions of predicted target setswith geneswhosep-values are lower
than 10−5 or which rank top 100, respectively, and each edition contains
240 gene sets corresponding to 240 TFs.
Predicted sets are likely to contain some false targets which may
bring noise to the analysis and encumber effective discoveries. Making
the threshold of the corresponding prediction methods more rigid
(like 10−5 used in our study) could solve this problem. Validated sets
aremore conﬁdent but may contain too few targets (sometimes under
10). Such sets can be considered as subsets sampled from all the
potential targets of a TF. The difference between the numbers of
available and true targets may cause unstable results. The limited
validated targets may also make detection of master TFs difﬁcult
especially if the expression time series of available targets all have
small correlations with that of their TF, but as long as a TF is
considered signiﬁcant with a relatively small target set (one sample
from the population), it is more likely to be a true discovery (as seen
for HNF4a). In a word, the usefulness of gene set approaches may rely
on the perfectness of the available gene sets.
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